My research focuses on clinical pharmacology, pharmacokinetics, and Phase I clinical trials, particularly in drug development and regulatory science. I am particularly interested in bioequivalence studies, crossover study designs, and the application of pharmacokinetic modeling to assess drug absorption, distribution, metabolism, and excretion.